IN THE NOW &
IN THE KNOW

vs-blog-header-600px

RESTORIDYN AVAILABLE IN EUROPE THROUGH PARTNERSHIP WITH LEHVOSS

APRIL 2020Verdure Sciences is proud to announce Restoridyn® is now available in Europe through our exclusive partner and distributor in Europe, LEHVOSS Nutrition. Verdure and LEHVOSS work in collaboration to offer Restoridyn, a sports ingredient uniquely positioned to support an expanding market of not only highly trained athletes, but also women and men that regularly or occasionally train to keep healthy.

people-doing-marathon-618612-2

Restoridyn® is a synergistic blend of proprietary polyphenols offering an adaptogenic nutritional approach for recovery and immunity support, which may lead to an increase in overall performance and stamina.* Restoridyn is the newest solution in a range of ingredients offered through the exclusive partnership with LEHVOSS for customers in Europe.

"We are very excited to offer this unique polyphenol blend, which combines two well known, proven and trendy actives such as curcuminoids and pomegranate ellagitannins to our customers in Europe, said Teresita Rudà," Marketing Manager at LEHVOSS Nutrition. "Through our partnership with Verdure Sciences, we are very pleased to launch Restoridyn to meet the needs of many food supplement brands in the increasingly popular sports nutrition market. This ingredient offers so many benefits for our customers with clinical research support and third-party verification that further benefits our customers in their finished product solutions,” she continued.

Verdure Sciences and LEHVOSS are excited to announce this development and look forward to more collaboration in the future. “We are so honored to have partnered with LEHVOSS for nearly 15 years now and to offer Restoridyn, as well as Longvida® Optimized Curcumin, Pomella® pomegranate extract, WokVel® Boswellia extract, Bacognize® Bacopa extract, and ashwagandha through this forged relationship. We are grateful to work with such an outstanding company to offer our ingredients, especially knowing the incredible effort the team brings to the table and the recognition the company brings to the brand. This partnership for Restoridyn is another step forward in offering our innovative ingredients to the global marketplace,” stated Leisha Jenkins, Marketing Associate with Verdure Sciences.†

RestoridynLogo

 

 

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Read more on Nutraceuticals Now HERE: Restoridyn, a Unique Blend of Curcuminoids & Ellagitannins, Available in Europe Through Partnership with Lehvoss
Read more on Nutraceutical Business Review HERE: Unique Blend of curcuminoids and ellagitannins now available in Europe
Read more on NutraIngredients HERE: Polyphenol blend available to European sports nutrition players

 

About Verdure Sciences®:  Verdure Sciences® manages ingredient innovation through the integration of supply network, production, and research platforms. With an expanding pipeline of proprietary, standardized botanical ingredients supported by pharmacokinetic, pharmacodynamic, and clinical research profiles, we work toward our unified vision to offer safe, effective ingredient solutions. Verdure Sciences® is a registered trademark of Verdure Sciences®, Inc.

Visit vs-corp.com for more information. Visit vs-corp.com/ip for the most current patent and trademark information. 

About Lehvoss:  LEHVOSS Nutrition is a business division of the LEHVOSS Group, dedicated to the marketing and distribution of nutraceutical ingredients and minerals for Food Supplements, Functional Foods and Feed applications, throughout Europe. Visit https://www.lehvoss-nutrition.com/ for more information.

 
 *Applies to references below:
1- Tanner EA et al. Poster Presentation – AAI 2018. J Immunol. 2018. 200(Supplement 1): 42.12LP-14.
2 - Gary MA et al. Inter J Exercise Science: Conference Proceedings. 2019. Vol 2(Issue 11): Article 41.
3 - Tanner EA et al. Inter J Exercise Science: Conference Proceedings. 2019. Vol 2(Issue 11): Article 42.

 

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Please note that the physiological activity of the ingredient(s) described herein is supported by the referenced clinical trial reports. Marketers of finished products containing the ingredient(s) described herein are responsible for determining whether claims made for such products are lawful and in compliance with the laws of the country in which they will market the products.
For our most current patent information, please visit: www.vs-corp.com/ip